Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- West China Hospital of Sichuan University (2024HXBH029)
- West China Hospital of Sichuan University (2023NSFSC1895)
- Sichuan University (GZC20231836)
- Sichuan Provincial Science and Technology Support Program
- Science and Technology Department of Sichuan Province (2024NSFSC1902)
This publication has 35 references indexed in Scilit:
- Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2021
- Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic reviewTechniques in Coloproctology, 2020
- Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trialEuropean Journal of Cancer, 2019
- FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialEuropean Journal of Cancer, 2018
- Neoadjuvant Treatment Strategies for Locally Advanced Rectal CancerClinical Oncology, 2016
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trialThe Lancet Oncology, 2012
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastasesCancer Chemotherapy and Pharmacology, 2007
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002